logo

Alexion Pharmaceuticals Inc. (ALXN)



Trade ALXN now with
  Date
  Headline
9/29/2021 2:11:32 AM AstraZeneca's Alexion Exercises Option To Acquire Caelum Biosciences For CAEL-101
7/14/2021 2:14:43 AM AstraZeneca Gets Final Regulatory Clearance For Proposed Acquisition Of Alexion From UK's CMA
7/6/2021 2:07:30 AM AstraZeneca Receives EU Clearance For Proposed Acquisition Of Alexion
7/6/2021 2:04:38 AM AstraZeneca Gets EU Clearance For Proposed Acquisition Of Alexion
6/11/2021 3:05:15 AM Caelum Biosciences And Alexion Announce New Phase 2 Safety And Tolerability Data For CAEL-101
5/25/2021 2:23:44 AM UK CMA To Assess AstraZeneca-Alexion Deal; Invites Comments On Transaction
5/11/2021 9:31:31 AM Alexion Shareholders Approve Acquisition By AstraZeneca; Deal Expected To Close In Q3
4/30/2021 8:04:53 AM Alexion Pharma Q1 GAAP EPS $2.86; Non-GAAP EPS $3.52
4/16/2021 8:37:36 AM AstraZeneca Receives US Clearance Of Proposed Acquisition Of Alexion
2/4/2021 8:08:59 AM Alexion Q4 Total Revenues $1.59 Bln, 15% Increase From Last Year